Injectable Bone Cements: A Generational Framework for Bioactivity, Porosity, and Mechanobiological Design at the Nanoscale

IF 4.8 Q2 ENGINEERING, BIOMEDICAL
Advanced Nanobiomed Research Pub Date : 2026-08-02 Epub Date: 2026-04-15 DOI:10.1002/anbr.202500311
Frank Fei, Yogambha Ramaswamy, Young Jung No
{"title":"Injectable Bone Cements: A Generational Framework for Bioactivity, Porosity, and Mechanobiological Design at the Nanoscale","authors":"Frank Fei,&nbsp;Yogambha Ramaswamy,&nbsp;Young Jung No","doi":"10.1002/anbr.202500311","DOIUrl":null,"url":null,"abstract":"<p>Injectable bone cements (IBCs) are widely used in orthopaedic and craniofacial applications due to their minimally invasive delivery and ability to provide early mechanical stabilisation. Despite substantial progress, clinical translation remains limited by persistent challenges, including insufficient bioactivity, poor control of porosity and interconnectivity, and the limited integration of mechanobiological design principles. Additional constraints arise from the need to balance injectability, setting behaviour, and mechanical performance. Most existing reviews categorise IBCs by material composition, often overlooking important conceptual advances in functionality. Here, we propose a generation-based classification framework that captures successive shifts in injectable cement design, from first-generation bioinert structural fillers to second-generation resorbable, osteoconductive systems, to third-generation bioactivity-enhanced doped and composite formulations, and finally to fourth-generation cements incorporating hierarchical macro- and nanoscale architectures. This latest generation integrates nanomaterials and engineered pore structures to regulate cell–matrix interactions, mechanotransduction, and tissue regeneration. Across each generation, we critically examine the interdependence of biological, mechanical, and rheological properties, highlighting how architectural and mechanical cues modulate cellular responses. By synthesising advances in materials science and mechanobiology, this review outlines emerging strategies for the design of regenerative, mechanobiologically informed IBCs.</p>","PeriodicalId":29975,"journal":{"name":"Advanced Nanobiomed Research","volume":"6 8","pages":""},"PeriodicalIF":4.8000,"publicationDate":"2026-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/anbr.202500311","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced Nanobiomed Research","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/anbr.202500311","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/4/15 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0

Abstract

Injectable bone cements (IBCs) are widely used in orthopaedic and craniofacial applications due to their minimally invasive delivery and ability to provide early mechanical stabilisation. Despite substantial progress, clinical translation remains limited by persistent challenges, including insufficient bioactivity, poor control of porosity and interconnectivity, and the limited integration of mechanobiological design principles. Additional constraints arise from the need to balance injectability, setting behaviour, and mechanical performance. Most existing reviews categorise IBCs by material composition, often overlooking important conceptual advances in functionality. Here, we propose a generation-based classification framework that captures successive shifts in injectable cement design, from first-generation bioinert structural fillers to second-generation resorbable, osteoconductive systems, to third-generation bioactivity-enhanced doped and composite formulations, and finally to fourth-generation cements incorporating hierarchical macro- and nanoscale architectures. This latest generation integrates nanomaterials and engineered pore structures to regulate cell–matrix interactions, mechanotransduction, and tissue regeneration. Across each generation, we critically examine the interdependence of biological, mechanical, and rheological properties, highlighting how architectural and mechanical cues modulate cellular responses. By synthesising advances in materials science and mechanobiology, this review outlines emerging strategies for the design of regenerative, mechanobiologically informed IBCs.

Abstract Image

可注射骨水泥:纳米级生物活性、孔隙度和机械生物学设计的世代框架
可注射骨水泥(IBCs)由于其微创输送和早期机械稳定的能力而广泛应用于骨科和颅面应用。尽管取得了实质性进展,但临床翻译仍然受到持续挑战的限制,包括生物活性不足,孔隙度和互联性控制不佳,机械生物学设计原则的有限整合。额外的限制来自于需要平衡可注入性、坐封行为和机械性能。大多数现有的评论根据材料组成对ibc进行分类,往往忽略了功能上重要的概念进展。在这里,我们提出了一个基于世代的分类框架,以捕捉可注射水泥设计的连续变化,从第一代生物惰性结构填料到第二代可吸收的骨传导系统,再到第三代生物活性增强的掺杂和复合配方,最后到第四代结合层次宏观和纳米级结构的水泥。这一最新一代集成了纳米材料和工程孔结构,以调节细胞-基质相互作用,机械转导和组织再生。在每一代中,我们都批判性地研究了生物、机械和流变特性的相互依赖性,强调了建筑和机械线索如何调节细胞反应。通过综合材料科学和机械生物学的进展,本综述概述了再生的、机械生物学通知的IBCs设计的新兴策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Advanced Nanobiomed Research
Advanced Nanobiomed Research nanomedicine, bioengineering and biomaterials-
CiteScore
5.00
自引率
5.90%
发文量
87
审稿时长
21 weeks
期刊介绍: Advanced NanoBiomed Research will provide an Open Access home for cutting-edge nanomedicine, bioengineering and biomaterials research aimed at improving human health. The journal will capture a broad spectrum of research from increasingly multi- and interdisciplinary fields of the traditional areas of biomedicine, bioengineering and health-related materials science as well as precision and personalized medicine, drug delivery, and artificial intelligence-driven health science. The scope of Advanced NanoBiomed Research will cover the following key subject areas: ▪ Nanomedicine and nanotechnology, with applications in drug and gene delivery, diagnostics, theranostics, photothermal and photodynamic therapy and multimodal imaging. ▪ Biomaterials, including hydrogels, 2D materials, biopolymers, composites, biodegradable materials, biohybrids and biomimetics (such as artificial cells, exosomes and extracellular vesicles), as well as all organic and inorganic materials for biomedical applications. ▪ Biointerfaces, such as anti-microbial surfaces and coatings, as well as interfaces for cellular engineering, immunoengineering and 3D cell culture. ▪ Biofabrication including (bio)inks and technologies, towards generation of functional tissues and organs. ▪ Tissue engineering and regenerative medicine, including scaffolds and scaffold-free approaches, for bone, ligament, muscle, skin, neural, cardiac tissue engineering and tissue vascularization. ▪ Devices for healthcare applications, disease modelling and treatment, such as diagnostics, lab-on-a-chip, organs-on-a-chip, bioMEMS, bioelectronics, wearables, actuators, soft robotics, and intelligent drug delivery systems. with a strong focus on applications of these fields, from bench-to-bedside, for treatment of all diseases and disorders, such as infectious, autoimmune, cardiovascular and metabolic diseases, neurological disorders and cancer; including pharmacology and toxicology studies.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书